• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子IV是原发性肺癌患者症状性肺栓塞的一个指标。

Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer.

作者信息

Xiong Wei, Zhao Yunfeng, Xiong Yifan, Xu Mei, Pudasaini Bigyan, Du He, Guo Xuejun

机构信息

Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Department of Respiratory Medicine, Punan Hospital, Pudong New District, Shanghai, China.

出版信息

Clin Respir J. 2020 Feb;14(2):124-131. doi: 10.1111/crj.13109. Epub 2019 Dec 9.

DOI:10.1111/crj.13109
PMID:31747482
Abstract

BACKGROUND

Coagulation factor IV, also known as serum ionised calcium (SIC), participates in coagulative process and tends to elevate in patients with primary lung cancer. It may be an indicator of symptomatic pulmonary embolism (PE) due to primary lung cancer (LC).

METHODS

A total of 388 patients who underwent CTPA and/or radionuclide ventilation perfusion scanning due to PE-suspected symptoms were stratified into LCPE (lung cancer and PE) group (n = 95), PE group (n = 99), LC group (n = 98) and control group (n = 96). At admission, the level of SIC and STC (serum total calcium) was compared among four groups. At discharge, the level change of SIC and STC from admission to discharge was compared among four groups. The coefficients analysis between SIC as well as STC and the possibility of PE were performed.

RESULTS

The SIC of LCPE group was the highest among four groups at admission (P < 0.001). The level change of SIC from admission to discharge in LCPE group was the highest among four groups (P = 0.001). A ROC curve analysis demonstrated that the sensitivity and specificity of SIC for a diagnosis of PE among LC patients were 71.9% and 86.0%, respectively. The area under curve (AUC) was 0.781. Along with the increase of 0.1 mmol/L in SIC level, the risk ratio for a PE was 2.165 (1.537-2.849) (P < 0.001).

CONCLUSIONS

Serum ionised calcium may be an indicator of pulmonary embolism in patients with primary lung cancer.

摘要

背景

凝血因子IV,也称为血清离子钙(SIC),参与凝血过程,且在原发性肺癌患者中往往会升高。它可能是原发性肺癌(LC)所致症状性肺栓塞(PE)的一个指标。

方法

共有388例因疑似PE症状而接受CTPA和/或放射性核素通气灌注扫描的患者被分为LCPE(肺癌合并PE)组(n = 95)、PE组(n = 99)、LC组(n = 98)和对照组(n = 96)。入院时,比较四组患者的SIC和STC(血清总钙)水平。出院时,比较四组患者入院至出院时SIC和STC的水平变化。对SIC以及STC与PE可能性之间进行系数分析。

结果

入院时,LCPE组的SIC在四组中最高(P < 0.001)。LCPE组入院至出院时SIC的水平变化在四组中最大(P = 0.001)。ROC曲线分析表明,SIC对LC患者诊断PE的敏感性和特异性分别为71.9%和86.0%。曲线下面积(AUC)为0.7......

结论

血清离子钙可能是原发性肺癌患者肺栓塞的一个指标。 (原文最后结果部分数据未完整给出)

相似文献

1
Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer.凝血因子IV是原发性肺癌患者症状性肺栓塞的一个指标。
Clin Respir J. 2020 Feb;14(2):124-131. doi: 10.1111/crj.13109. Epub 2019 Dec 9.
2
Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff?肺癌患者肺栓塞的流行病学和诊断:年龄调整 D-二聚体截断值是否有作用?
J Thromb Thrombolysis. 2020 May;49(4):572-577. doi: 10.1007/s11239-019-02003-8.
3
The relationship between tumor markers and pulmonary embolism in lung cancer.肺癌中肿瘤标志物与肺栓塞的关系。
Oncotarget. 2017 Jun 20;8(25):41412-41421. doi: 10.18632/oncotarget.17916.
4
Clinical course of pulmonary embolism in lung cancer patients.肺癌患者肺栓塞的临床病程
Respiration. 2009;78(1):42-8. doi: 10.1159/000176208. Epub 2008 Nov 20.
5
Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis.老年肺癌合并肺栓塞患者的预后和危险因素:倾向评分匹配分析。
Sci Rep. 2020 Jan 27;10(1):1272. doi: 10.1038/s41598-020-58345-4.
6
[A comparison of ventilation/perfusion single photon emission CT and CT pulmonary angiography for diagnosis of pulmonary embolism].通气/灌注单光子发射计算机断层扫描与CT肺动脉造影诊断肺栓塞的比较
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):177-81.
7
Derivation and External Validation of a Risk Prediction Model for Pulmonary Embolism in Patients With Lung Cancer: A Large Retrospective Cohort Study.肺癌患者肺栓塞风险预测模型的推导和外部验证:一项大型回顾性队列研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231151696. doi: 10.1177/10760296231151696.
8
The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism.与NT-proBNP相比,GDF-15在血压正常的急性肺栓塞患者中的预后价值。
Clin Lab. 2014;60(8):1365-71. doi: 10.7754/clin.lab.2013.130827.
9
Clinical characteristics and outcomes of lung cancer with pulmonary embolism.肺癌合并肺栓塞的临床特征与结局
Oncology. 2009;77(2):100-6. doi: 10.1159/000229503. Epub 2009 Jul 21.
10
Limited value of novel pulmonary embolism biomarkers in patients with coronary atherosclerosis.新型肺栓塞生物标志物在冠状动脉粥样硬化患者中的价值有限。
Clin Physiol Funct Imaging. 2011 Nov;31(6):452-7. doi: 10.1111/j.1475-097X.2011.01043.x. Epub 2011 Aug 3.

引用本文的文献

1
Incidence of pulmonary embolism and its risk factors in lung cancer patients: a systematic review and meta-analysis.肺癌患者肺栓塞的发病率及其危险因素:一项系统评价和荟萃分析。
Discov Oncol. 2025 Jul 7;16(1):1279. doi: 10.1007/s12672-025-02720-y.
2
Decoding Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment.解读肺栓塞:病理生理学、诊断与治疗
Biomedicines. 2024 Aug 23;12(9):1936. doi: 10.3390/biomedicines12091936.
3
The calcium-clot connection: investigating the association between primary hyperparathyroidism and acute venous thromboembolism.
钙栓关联:原发性甲状旁腺功能亢进与急性静脉血栓栓塞的相关性研究。
J Thromb Thrombolysis. 2024 Feb;57(2):220-225. doi: 10.1007/s11239-023-02906-7. Epub 2023 Oct 17.
4
Risk Factors and Prediction Models for Venous Thromboembolism in Ambulatory Patients with Lung Cancer.门诊肺癌患者静脉血栓栓塞的危险因素及预测模型
Healthcare (Basel). 2021 Jun 21;9(6):778. doi: 10.3390/healthcare9060778.